Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

Skin Fragility: Perspectives on Evidence-based Therapies.

Bruckner-Tuderman L.

Acta Derm Venereol. 2020 Feb 12;100(5):adv00053. doi: 10.2340/00015555-3398.

2.

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option.

Schauer F, Ishii N, Mockenhaupt M, Bruckner-Tuderman L, Hashimoto T, Kiritsi D.

Front Immunol. 2020 Jan 21;10:3116. doi: 10.3389/fimmu.2019.03116. eCollection 2019.

3.

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.

Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich MP, Martinez AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K, Uitto J, Woodley DT, Zambruno G, Mellerio JE.

Br J Dermatol. 2020 Feb 4. doi: 10.1111/bjd.18921. [Epub ahead of print] Review.

PMID:
32017015
4.

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa.

Diociaiuti A, Steinke H, Nyström A, Schwieger-Briel A, Meiss F, Pfannenberg C, Bruckner-Tuderman L, Ruf J, De Vito R, El Hachem M, Kiritsi D.

Orphanet J Rare Dis. 2019 Dec 3;14(1):278. doi: 10.1186/s13023-019-1262-7.

5.

STAT3 targeting in dystrophic epidermolysis bullosa.

Mittapalli VR, Kühl T, Kuzet SE, Gretzmeier C, Kiritsi D, Gaggioli C, Bruckner-Tuderman L, Nyström A.

Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18639. [Epub ahead of print] No abstract available.

PMID:
31675440
6.

Flightless I, a contributing factor to skin blistering in Kindler syndrome patients?

Kopecki Z, Has C, Yang G, Bruckner-Tuderman L, Cowin A.

J Cutan Pathol. 2020 Feb;47(2):186-189. doi: 10.1111/cup.13597. Epub 2019 Nov 6. No abstract available.

PMID:
31614010
7.

Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn.

Higgins R, Jensen AN, Wachstein J, Bruckner-Tuderman L, Spiegel R, Traber H, Achermann J, Schaller M, Fehrenbacher B, Röcken M, Ignatova D, Chang YT, Fischer T, Schwieger-Briel AE, French LE, Hoetzenecker W, Hornung R, Malzacher A, Cozzio A, Navarini A, Has C, Guenova E.

Acta Derm Venereol. 2020 Jan 30;100(1):adv00041. doi: 10.2340/00015555-3313. No abstract available.

8.

Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study.

Reimer A, Hess M, Schwieger-Briel A, Kiritsi D, Schauer F, Schumann H, Bruckner-Tuderman L, Has C.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18475. [Epub ahead of print]

PMID:
31487386
9.

Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Reimer A, Lu S, He Y, Bruckner-Tuderman L, Technau-Hafsi K, Meiss F, Has C, von Bubnoff D.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e1-e3. doi: 10.1111/jdv.15835. Epub 2019 Sep 2. No abstract available.

PMID:
31374134
10.

Laudatio zum 80. Geburtstag für Prof. Dr. med. Dr. h.c. mult. Gerd Plewig.

French L, Prinz JC, Bruckner-Tuderman L.

J Dtsch Dermatol Ges. 2019 Jun;17(6):676-677. doi: 10.1111/ddg.13853. No abstract available. Erratum in: J Dtsch Dermatol Ges. 2019 Aug;17(8):871.

PMID:
31241835
11.

Newer Treatment Modalities in Epidermolysis Bullosa.

Bruckner-Tuderman L.

Indian Dermatol Online J. 2019 May-Jun;10(3):244-250. doi: 10.4103/idoj.IDOJ_287_18. Review.

12.

Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders.

Spörrer M, Prochnicki A, Tölle RC, Nyström A, Esser PR, Homberg M, Athanasiou I, Zingkou E, Schilling A, Gerum R, Thievessen I, Winter L, Bruckner-Tuderman L, Fabry B, Magin TM, Dengjel J, Schröder R, Kiritsi D.

EBioMedicine. 2019 Jun;44:502-515. doi: 10.1016/j.ebiom.2019.04.062. Epub 2019 May 9.

13.

[In honor of Prof. Dr. med. Dr. h.c. mult. Gerd Plewig on the occasion of his 80th birthday : Gerd Plewid-a lifetime for dermatology].

Bruckner-Tuderman L, French L, Prinz JC.

Hautarzt. 2019 May;70(5):386-387. doi: 10.1007/s00105-019-4393-9. German. No abstract available.

PMID:
31073763
14.

[Structured Career Pathways in the University Medicine - From Promotion to Clinician Scientist Programs].

Thimme R, Pahl HL, Werner K, Nagel IE, Bruckner-Tuderman L.

Dtsch Med Wochenschr. 2019 Apr;144(7):489-493. doi: 10.1055/a-0851-5750. Epub 2019 Mar 29. German.

PMID:
30925606
15.

Wir feiern die 50. DDG Tagung im Mai 2019.

Bruckner-Tuderman L.

J Dtsch Dermatol Ges. 2019 Mar;17(3):237-238. doi: 10.1111/ddg.13764. No abstract available.

PMID:
30920742
16.

Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa.

Cianfarani F, De Domenico E, Nyström A, Mastroeni S, Abeni D, Baldini E, Ulisse S, Uva P, Bruckner-Tuderman L, Zambruno G, Castiglia D, Odorisio T.

Matrix Biol. 2019 Aug;81:3-16. doi: 10.1016/j.matbio.2018.12.001. Epub 2018 Dec 5.

PMID:
30528862
17.

Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany.

Reimer A, Bruckner-Tuderman L, Ott H.

Orphanet J Rare Dis. 2018 Nov 8;13(1):197. doi: 10.1186/s13023-018-0944-x. Print 2018 Oct 26.

18.

Metadata Correction: Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study.

Litzkendorf S, Hartz T, Göbel J, Storf H, Pauer F, Babac A, Lührs V, Bruckner-Tuderman L, Schauer F, Schmidtke J, Biehl L, Wagner T, Graf von der Schulenburg JM, Frank M.

JMIR Res Protoc. 2018 Sep 19;7(9):e11248. doi: 10.2196/11248.

19.

A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.

Schauer F, Kern JS, Virtic O, Technau-Hafsi K, Meiss F, Thoma K, Athanasiou I, Sitaru C, Di Zenzo G, Izumi K, Nishie W, Shimizu H, Bruckner-Tuderman L, Kiritsi D.

Br J Dermatol. 2019 Jan;180(1):231-232. doi: 10.1111/bjd.17146. Epub 2018 Nov 13. No abstract available.

PMID:
30188568
20.

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Cho RJ, Alexandrov LB, den Breems NY, Atanasova VS, Farshchian M, Purdom E, Nguyen TN, Coarfa C, Rajapakshe K, Prisco M, Sahu J, Tassone P, Greenawalt EJ, Collisson EA, Wu W, Yao H, Su X, Guttmann-Gruber C, Hofbauer JP, Hashmi R, Fuentes I, Benz SC, Golovato J, Ehli EA, Davis CM, Davies GE, Covington KR, Murrell DF, Salas-Alanis JC, Palisson F, Bruckner AL, Robinson W, Has C, Bruckner-Tuderman L, Titeux M, Jonkman MF, Rashidghamat E, Lwin SM, Mellerio JE, McGrath JA, Bauer JW, Hovnanian A, Tsai KY, South AP.

Sci Transl Med. 2018 Aug 22;10(455). pii: eaas9668. doi: 10.1126/scitranslmed.aas9668.

PMID:
30135250
21.

In Memoriam Professor Dr. Erwin Schöpf.

Bruckner-Tuderman L, Simon JC.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1067-1068. doi: 10.1111/ddg.13593. No abstract available.

PMID:
30117691
22.

Matrix molecules and skin biology.

Nyström A, Bruckner-Tuderman L.

Semin Cell Dev Biol. 2019 May;89:136-146. doi: 10.1016/j.semcdb.2018.07.025. Epub 2018 Aug 4. Review.

PMID:
30076963
23.

Successful Multidisciplinary Treatment of Chronic Facial Wounds in Junctional Epidermolysis Bullosa.

Reimer A, Laszig R, Pfeiffer J, Eberwein P, Mittelviefhaus H, Bruckner-Tuderman L, Has C.

Acta Derm Venereol. 2018 Jul 11;98(7):711-712. doi: 10.2340/00015555-2934. No abstract available.

24.

Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study.

Litzkendorf S, Hartz T, Göbel J, Storf H, Pauer F, Babac A, Lührs V, Bruckner-Tuderman L, Schauer F, Schmidtke J, Biehl L, Wagner T, Graf von der Schulenburg JM, Frank M.

JMIR Res Protoc. 2018 May 11;7(5):e112. doi: 10.2196/resprot.7425. Erratum in: JMIR Res Protoc. 2018 Sep 19;7(9):e11248.

25.

Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone.

Has C, Nyström A, Saeidian AH, Bruckner-Tuderman L, Uitto J.

Matrix Biol. 2018 Oct;71-72:313-329. doi: 10.1016/j.matbio.2018.04.001. Epub 2018 Apr 5. Review.

PMID:
29627521
26.

Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa.

Nyström A, Bruckner-Tuderman L.

Matrix Biol. 2018 Aug;68-69:547-560. doi: 10.1016/j.matbio.2018.01.016. Epub 2018 Jan 31. Review.

PMID:
29391280
27.

EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.

Uitto J, Bruckner-Tuderman L, McGrath JA, Riedl R, Robinson C.

J Invest Dermatol. 2018 May;138(5):1010-1016. doi: 10.1016/j.jid.2017.12.016. Epub 2018 Jan 31.

PMID:
29391251
28.

Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes.

Thriene K, Grüning BA, Bornert O, Erxleben A, Leppert J, Athanasiou I, Weber E, Kiritsi D, Nyström A, Reinheckel T, Backofen R, Has C, Bruckner-Tuderman L, Dengjel J.

Mol Cell Proteomics. 2018 Apr;17(4):565-579. doi: 10.1074/mcp.RA117.000437. Epub 2018 Jan 11.

29.

Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.

Nyström A, Bornert O, Kühl T, Gretzmeier C, Thriene K, Dengjel J, Pfister-Wartha A, Kiritsi D, Bruckner-Tuderman L.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E705-E714. doi: 10.1073/pnas.1709111115. Epub 2018 Jan 5.

30.

Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases.

Lacroix M, Tessier A, Dumestre-Pérard C, Vadon-Le Goff S, Gout E, Bruckner-Tuderman L, Kiritsi D, Nyström A, Ricard-Blum S, Moali C, Hulmes DJS, Thielens NM.

Sci Rep. 2017 Dec 5;7(1):16958. doi: 10.1038/s41598-017-17318-w.

31.

Natural history and clinical outcome of junctional epidermolysis bullosa generalized intermediate due to a LAMA3 mutation.

Reimer A, Schwieger-Briel A, He Y, Leppert J, Schauer F, Kiritsi D, Schneider H, Ott H, Bruckner-Tuderman L, Has C.

Br J Dermatol. 2018 Apr;178(4):973-975. doi: 10.1111/bjd.16088. Epub 2018 Feb 7. No abstract available.

PMID:
29077994
32.

Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression.

Galiger C, Löffek S, Stemmler MP, Kroeger JK, Mittapalli VR, Fauth L, Esser PR, Kern JS, Meiss F, Laßmann S, Bruckner-Tuderman L, Franzke CW.

Mol Ther. 2018 Jan 3;26(1):17-30. doi: 10.1016/j.ymthe.2017.09.022. Epub 2017 Sep 27.

33.

Wound healing in epidermolysis bullosa.

Bruckner-Tuderman L, Mellerio JE.

Br J Dermatol. 2017 Nov;177(5):e193-e195. doi: 10.1111/bjd.15572. Epub 2017 Oct 10. No abstract available.

PMID:
28718937
34.

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa.

Atanasova VS, Jiang Q, Prisco M, Gruber C, Piñón Hofbauer J, Chen M, Has C, Bruckner-Tuderman L, McGrath JA, Uitto J, South AP.

J Invest Dermatol. 2017 Sep;137(9):1842-1849. doi: 10.1016/j.jid.2017.05.011. Epub 2017 May 24. Review.

35.

Abstracts of the 52nd Workshop for Pediatric Research : Frankfurt, Germany. 27-28 October 2016.

van den Bruck R, Weil PP, Ziegenhals T, Schreiner P, Juranek S, Gödde D, Vogel S, Schuster F, Orth V, Dörner J, Pembaur D, Röper M, Störkel S, Zirngibl H, Wirth S, Jenke ACW, Postberg J, Boy N, Heringer J, Haege G, Glahn EM, Hoffmann GF, Garbade SF, Burgard P, Kölker S, Chao CM, Yahya F, Moiseenko A, Shrestha A, Ahmadvand N, Quantius J, Wilhelm J, El-Agha E, Zimmer KP, Bellusci S, Staufner C, Kölker S, Prokisch H, Hoffmann GF, Seeliger S, Müller M, Hippe A, Steinkraus H, Wauer R, Lachmann B, Hofmann SR, Hedrich CM, Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, Metzler M, Thieme S, Bandoła J, Richter C, Ryser M, Jamal A, Ashton MP, von Bonin M, Kuhn M, Hedrich CM, Bonifacio E, Berner R, Brenner S, Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, Tardieu M, Metzler M, Bruckner-Tuderman L, Schneider H, Bohne F, Langer D, Cencic R, Eggermann T, Zechner U, Pelletier J, Zepp F, Enklaar T, Prawitt D, Pech M, Weckmann M, Heinsen FA, Franke A, Happle C, Dittrich AM, Hansen G, Fuchs O, von Mutius E, Oliver BG, Kopp MV, Paret C, Russo A, Theruvath J, Keller B, El Malki K, Lehmann N, Wingerter A, Neu MA, Aslihan GA, Wagner W, Sommer C, Pietsch T, Seidmann L, Faber J, Schreiner F, Ackermann M, Michalik M, Rother E, Bilkei-Gorzo A, Racz I, Bindila L, Lutz B, Dötsch J, Zimmer A, Woelfle J, Fischer HS, Ullrich TL, Bührer C, Czernik C, Schmalisch G, Stein R, Hofmann SR, Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ, Loges NT, Frommer AT, Wallmeier J, Omran H, Öner-Sieben S, Gimpfl M, Rozman J, Irmler M, Beckers J, De Angelis MH, Roscher A, Wolf E, Ensenauer R, Nemes K, Frühwald M, Hasselblatt M, Siebert R, Kordes U, Kool M, Wang H, Hardy H, Refai O, Barwick KES, Zimmerman HH, Weis J, Baple EL, Crosby AH, Cirak S, Hellmuth C, Uhl O, Standl M, Heinrich J, Thiering E, Koletzko B, Blümel L, Kerl K, Picard D, Frühwald MC, Liebau MC, Reifenberger G, Borkhardt A, Hasselblatt M, Remke M, Tews D, Wabitsch M, Fischer-Posovszky P, Westhoff MA, Nonnenmacher L, Langhans J, Schneele L, Trenkler N, Debatin KM.

Mol Cell Pediatr. 2017 May;4(Suppl 1):5. doi: 10.1186/s40348-017-0071-0. No abstract available.

36.

[Research funding for rare diseases in Germany].

Wissing F, Bruckner-Tuderman L.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):550-555. doi: 10.1007/s00103-017-2532-y. German.

PMID:
28289776
37.

Absence of the Integrin α3 Subunit Induces an Activated Phenotype in Human Keratinocytes.

Pazzagli C, He Y, Busch H, Esser P, Kiritsi D, Gache Y, Bruckner-Tuderman L, Boerries M, Has C.

J Invest Dermatol. 2017 Jun;137(6):1387-1391. doi: 10.1016/j.jid.2017.01.018. Epub 2017 Feb 3. No abstract available.

38.

Gene Therapy for Epidermolysis Bullosa: Sticky Business.

Nyström A, Bruckner-Tuderman L.

Mol Ther. 2016 Dec;24(12):2035-2036. doi: 10.1038/mt.2016.199. No abstract available.

39.

UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome.

Maier K, He Y, Wölfle U, Esser PR, Brummer T, Schempp C, Bruckner-Tuderman L, Has C.

Hum Mol Genet. 2016 Dec 15;25(24):5339-5352. doi: 10.1093/hmg/ddw350.

PMID:
27798104
40.

Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.

Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, Tardieu M, Metzler M, Bruckner-Tuderman L, Schneider H.

J Invest Dermatol. 2016 Nov;136(11):2150-2157. doi: 10.1016/j.jid.2016.06.609. Epub 2016 Jun 29.

41.

Successful Treatment of Refractory Pityriasis Rubra Pilaris With Secukinumab.

Schuster D, Pfister-Wartha A, Bruckner-Tuderman L, Schempp CM.

JAMA Dermatol. 2016 Nov 1;152(11):1278-1280. doi: 10.1001/jamadermatol.2016.3885. No abstract available. Erratum in: JAMA Dermatol. 2017 Jan 1;153(1):112.

PMID:
27706476
42.

Keratin-dependent thymic stromal lymphopoietin expression suggests a link between skin blistering and atopic disease.

Kumar V, Behr M, Kiritsi D, Scheffschick A, Grahnert A, Homberg M, Schwieger-Briel A, Jakob T, Bruckner-Tuderman L, Magin TM.

J Allergy Clin Immunol. 2016 Nov;138(5):1461-1464.e6. doi: 10.1016/j.jaci.2016.04.046. Epub 2016 Jun 15. No abstract available.

PMID:
27527262
43.

Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa.

Uitto J, Has C, Vahidnezhad H, Youssefian L, Bruckner-Tuderman L.

Matrix Biol. 2017 Jan;57-58:76-85. doi: 10.1016/j.matbio.2016.07.009. Epub 2016 Aug 3. Review.

PMID:
27496350
44.

Generation of a Functional Non-Shedding Collagen XVII Mouse Model: Relevance of Collagen XVII Shedding in Wound Healing.

Jacków J, Schlosser A, Sormunen R, Nyström A, Sitaru C, Tasanen K, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 Feb;136(2):516-525. doi: 10.1016/j.jid.2015.10.060. Epub 2015 Nov 18.

45.

Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses.

Kühl T, Mezger M, Hausser I, Guey LT, Handgretinger R, Bruckner-Tuderman L, Nyström A.

J Invest Dermatol. 2016 Jun;136(6):1116-1123. doi: 10.1016/j.jid.2016.02.002. Epub 2016 Feb 18.

46.

Collagen XVII Shedding Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR Signaling.

Jacków J, Löffek S, Nyström A, Bruckner-Tuderman L, Franzke CW.

J Invest Dermatol. 2016 May;136(5):1031-1041. doi: 10.1016/j.jid.2016.01.012. Epub 2016 Jan 28.

47.

Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015.

Uitto J, Bruckner-Tuderman L, Christiano AM, McGrath JA, Has C, South AP, Kopelan B, Robinson EC.

J Invest Dermatol. 2016 Feb;136(2):352-358. doi: 10.1016/j.jid.2015.10.050. Review.

48.

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L.

Cancer Res. 2016 Feb 15;76(4):940-51. doi: 10.1158/0008-5472.CAN-15-1348. Epub 2015 Dec 16.

49.

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L.

EMBO Mol Med. 2015 Sep;7(9):1211-28. doi: 10.15252/emmm.201505061.

50.

A Deep-Intronic FERMT1 Mutation Causes Kindler Syndrome: An Explanation for Genetically Unsolved Cases.

Chmel N, Danescu S, Gruler A, Kiritsi D, Bruckner-Tuderman L, Kreuter A, Kohlhase J, Has C.

J Invest Dermatol. 2015 Nov;135(11):2876-2879. doi: 10.1038/jid.2015.227. Epub 2015 Jun 17. No abstract available.

Supplemental Content

Loading ...
Support Center